Loxoprofen
- Generic Name
- Loxoprofen
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H18O3
- CAS Number
- 68767-14-6
- Unique Ingredient Identifier
- 3583H0GZAP
- Background
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug. It is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. A transdermal preparation was approved for use in Japan in January 2006.
- Indication
Loxoprofen is non-steroidal anti-inflammatory medication (NSAID) indicated for pain and inflammation related to musculoskeletal and joint disorders. In addition to its effects on pain, it is an antipyretic and anti-inflammatory medication.
- Associated Conditions
- Musculoskeletal Pain, Rheumatism, Soft Tissue Injury
- Associated Therapies
- -
Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 47
- Registration Number
- NCT02467504
- Locations
- 🇨🇳
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing, China
East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia
- Conditions
- Interventions
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2015-11-24
- Lead Sponsor
- Kyunghee University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01922466
- Locations
- 🇰🇷
Spine Center, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
- Conditions
- Interventions
- First Posted Date
- 2013-01-30
- Last Posted Date
- 2016-10-10
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 183
- Registration Number
- NCT01779271
- Locations
- 🇰🇷
Chung-Ang University Hospital, South Korea, Seoul, Korea, Republic of
Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2011-12-14
- Last Posted Date
- 2012-03-21
- Lead Sponsor
- Kyunghee University Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT01491321
- Locations
- 🇰🇷
Spine Center, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of
Study Of Celecoxib In Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2021-02-02
- Target Recruit Count
- 190
- Registration Number
- NCT00994461
- Locations
- 🇯🇵
Pfizer Investigational Site, Shinjuku-ku, Tokyo, Japan
Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00676117
- Locations
- 🇯🇵
Research Site, Osaka-city, Osaka, Japan
Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan
- Conditions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2021-03-03
- Target Recruit Count
- 1234
- Registration Number
- NCT00141154
- Locations
- 🇯🇵
Pfizer Investigational Site, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.